Publications by the researcher in collaboration with Pablo Dominguez Erquicea (17)

2023

  1. Bleeding and embolic risk in patients with atrial fibrillation and cancer

    Revista Espanola de Cardiologia, Vol. 76, Núm. 5, pp. 344-352

  2. Comparison of Stroke and Bleeding Risk Profile in Patients With Atrial Fibrillation and Chronic Kidney Disease

    American Journal of Cardiology, Vol. 196, pp. 31-37

  3. Predictive value of bleeding risk scores in elderly patients with atrial fibrillation and oral anticoagulation

    Journal of Geriatric Cardiology, Vol. 20, Núm. 9, pp. 684-692

  4. Suboptimal anticoagulation with vitamin K antagonists: the need to change the national therapeutic positioning report

    Revista Espanola de Cardiologia, Vol. 76, Núm. 3, pp. 197-198

2022

  1. Comparison of Outcomes in Patients With Atrial Fibrillation Under Oral Anticoagulation Therapy Analyzed by Body Weight (<60, 60 to 100, and >100 kg)

    American Journal of Cardiology, Vol. 184, pp. 41-47

  2. Effect of mitral regurgitation on stroke risk in patients with non-rheumatic atrial fibrillation

    Archives of Cardiovascular Diseases, Vol. 115, Núm. 8-9, pp. 448-456

  3. Incidence and Predictors of Bleeding in Patients With Cancer and Atrial Fibrillation

    American Journal of Cardiology, Vol. 167, pp. 139-146

  4. Rationale and design of the Dapagliflozin after Transcatheter Aortic Valve Implantation (DapaTAVI) randomized trial

    European Journal of Heart Failure, Vol. 24, Núm. 3, pp. 581-588

  5. Trade-off between the effects of embolic versus bleeding events on mortality in elderly patients with atrial fibrillation

    Revista Espanola de Cardiologia, Vol. 75, Núm. 4, pp. 334-342

2021

  1. Incidence, predictors of bleeding and prognosis of bleeding in anticoagulated nonagenarian patients with atrial fibrillation

    International Journal of Cardiology, Vol. 327, pp. 217-222

  2. Predictors of Inappropriate Dosing of Direct Oral Anticoagulants in Nonagenarian Patients With Atrial Fibrillation

    Journal of the American Medical Directors Association

  3. Safety of digoxin in nonagenarian patients with atrial fibrillation: lessons from the Spanish Multicenter Registry

    Journal of Geriatric Cardiology, Vol. 18, Núm. 10, pp. 809-815

2020

  1. Impact of anticoagulation in patients with dementia and atrial fibrillation. Results of the CardioCHUVI-FA registry

    Revista Espanola de Cardiologia, Vol. 73, Núm. 11, pp. 877-884

  2. Impact of malnutrition in the embolic-haemorrhagic trade-off of elderly patients with atrial fibrillation

    Europace : European pacing, arrhythmias, and cardiac electrophysiology : journal of the working groups on cardiac pacing, arrhythmias, and cardiac cellular electrophysiology of the European Society of Cardiology, Vol. 22, Núm. 6, pp. 878-887

  3. Multivessel coronary thrombosis in a patient with COVID-19 pneumonia

    European Heart Journal

  4. Vitamin K Antagonists and Direct Oral Anticoagulants in Nonagenarian Patients With Atrial Fibrillation

    Journal of the American Medical Directors Association, Vol. 21, Núm. 3, pp. 367-373.e1

2019

  1. Renin–Angiotensin System Blockade and Risk of Heart Failure After Myocardial Infarction Based on Left Ventricular Ejection Fraction: A Retrospective Cohort Study

    American Journal of Cardiovascular Drugs, Vol. 19, Núm. 5, pp. 487-495